AzTrials
AzTrials

Kidney StonesNCT07349992

Retrograde Intrarenal Surgery (RIRS) With High-Power Laser and Flexible, Navigable Suction Access Sheath (FANS) vs Mini-Percutaneous Nephrolithotomy (miniPCNL) for 2-3 cm Renal Stones

A study testing Retrograde Intrarenal Surgery and Mini Percutaneous Nephrolithotomy in people with Kidney Stones and Nephrolithiasis, run by Necmettin Erbakan University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This prospective cohort study aims to compare the safety and efficacy of retrograde intrarenal surgery combined with a high-power Holmium:YAG laser and flexible navigable suction access sheath versus mini-percutaneous nephrolithotomy in patients with 2-3 cm renal stones. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Kidney Stones, Nephrolithiasis
What is being tested?
Retrograde Intrarenal Surgery and Mini Percutaneous Nephrolithotomy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Jun 2022to 1 Jun 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age ≥18 years
  • Kidney stones measuring 2-3 cm
  • Suitable for Retrograde Intrarenal Surgery (RIRS) or Mini-Percutaneous Nephrolithotomy (MiniPCNL)
  • Provided written informed consent

Who cannot join

  • Pregnancy
  • Renal transplantation
  • Congenital renal anomalies
  • Uncorrectable coagulopathy

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Necmettin Erbakan University Medical Faculty

    Konya, Konya

Other trials in Turkey (Türkiye)

About this study

Official title: Flexible Ureterorenoscopy With High-Power Holmium: YAG Laser and Flexible, Navigable Suction Access Sheath vs Mini-Percutaneous Nephrolithotomy in 2-3 cm Kidney Stones Treatment: A Prospective Cohort Study

This prospective cohort study aims to compare the safety and efficacy of retrograde intrarenal surgery combined with a high-power Holmium:YAG laser and flexible navigable suction access sheath versus mini-percutaneous nephrolithotomy in patients with 2-3 cm renal stones.

Being tested
Retrograde Intrarenal Surgery, Mini Percutaneous Nephrolithotomy
Medical subject headings
Kidney Calculi, Nephrolithiasis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Retrograde Intrarenal SurgeryProcedure or surgery

    We performed retrograde intrarenal surgery combined with a high-power Holmium:YAG laser and flexible navigable suction access sheath in patients with 2-3 cm renal stones.

  • Mini Percutaneous NephrolithotomyProcedure or surgery

    We performed mini-percutaneous nephrolithotomy in patients with 2-3 cm renal stones.

Study groups in NCT07349992
Study groupRoleWhat they receive
Retrograde Intrarenal Surgery (RIRS) GroupExperimentalIntervention: Procedure-Retrograde Intrarenal Surgery
Receives: Procedure: Retrograde Intrarenal Surgery
Mini-Percutaneous Nephrolithotomy (MiniPCNL) GroupExperimentalIntervention: Procedure- Mini Percutaneous Nephrolithotomy
Receives: Procedure: Mini Percutaneous Nephrolithotomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Stone-Free Rate

    Measured: 1 month

Secondary outcomes (3)
  1. Hemoglobin change

    Measured: postoperative first day

  2. Fluoroscopy time

    Measured: Perioperative

  3. Complications

    Measured: up to 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Jan 2026
  2. Study start1 Jun 2022
  3. Primary completion1 Jun 2024
  4. Study completion1 Jun 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07349992
Sponsor's protocol ID
RIRS-MiniPCNL-2022
Status last verified
Jan 2026
First submitted
8 Jan 2026
Last updated
20 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Publications

  • Kilinc MT, Goger YE, Cavdar OF, Taskapu HH, Ozkent MS. Comparative outcomes of flexible ureterorenoscopy with high-power holmium: YAG laser and flexible, navigable suction access sheath vs mini-percutaneous nephrolithotomy in 2-3 cm kidney stones treatment: a prospective cohort study. BMC Urol. 2026 Jul 11. doi: 10.1186/s12894-026-02250-x. Online ahead of print.

    PubMed 42436463

Questions about this trial

What is this clinical trial studying?

A study testing Retrograde Intrarenal Surgery and Mini Percutaneous Nephrolithotomy in people with Kidney Stones and Nephrolithiasis, run by Necmettin Erbakan University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Stone-Free Rate (time frame: 1 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07349992, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in